{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:46Z","timestamp":1787016946908,"version":"build-2736575974"},"reference-count":14,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007602","name":"Programme Grants for Applied Research","doi-asserted-by":"publisher","award":["RP-PG-0216-20001"],"award-info":[{"award-number":["RP-PG-0216-20001"]}],"id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2024,11,6]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Many people with inflammatory bowel disease (IBD) experience fatigue, pain and faecal incontinence that some feel are inadequately addressed. It is unknown how many have potentially reversible medical issues underlying these symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a study testing the feasibility of a patient-reported symptom checklist and nurse-administered management algorithm (\u2018Optimise\u2019) to manage common medical causes of IBD-related fatigue, pain and faecal incontinence. We conducted qualitative interviews with nurses implementing the algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>515 individuals reporting IBD-related symptoms were invited to participate, of whom 201 (39%) consented. 194\/201 (97%) returned the symptom checklist, of whom 157 (81%) returned a postal faecal calprotectin sample. Five (3%) participants reported \u2018red flags\u2019 and 31\/157 (20%) participants had a faecal calprotectin result \u2265200\u2009\u00b5g\/g, of whom 12 (8%) were judged to have likely active inflammation when clinical symptoms and disease history were reviewed. The algorithm suggested at least one clinical test or intervention for fatigue, pain or faecal incontinence in 67 (43%) participants, of whom 25 (37%) declined. Among 87 participants for whom clinical actions were indicated, 57 (66%) completed follow-up outcomes 3\u2009months after algorithm implementation. Three nurses interviewed found the Optimise algorithm easy to administer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Implementing the Optimise checklist and algorithm appears feasible in UK clinical practice, with adjustments needed to minimise missing items. Not all patients accepted algorithm-indicated interventions, but a yield of 43% with symptoms having potentially reversible causes detected is clinically useful. Nurses endorsed ease and utility of the implementation process. Optimise now needs clinical effectiveness to be assessed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2024-001585","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T23:50:12Z","timestamp":1734738612000},"page":"e001585","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Optimising fatigue, abdominal pain and faecal incontinence in people with inflammatory bowel disease (IBD-BOOST Optimise): feasibility study of a checklist and algorithm for initial nurse-led management"],"prefix":"10.1136","volume":"11","author":[{"given":"Imogen","family":"Stagg","sequence":"first","affiliation":[{"name":"St Mark's Hospital and Academic Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-6076","authenticated-orcid":false,"given":"Ailsa","family":"Hart","sequence":"additional","affiliation":[{"name":"St Mark's Hospital and Academic Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionn","family":"Cl\u00e9irigh B\u00fcttner","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4965-757X","authenticated-orcid":false,"given":"Asma","family":"Fikree","sequence":"additional","affiliation":[{"name":"University College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6158-5135","authenticated-orcid":false,"given":"John","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Frederic","family":"LeBlanc","sequence":"additional","affiliation":[{"name":"University of Montreal, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7273-8106","authenticated-orcid":false,"given":"Sonia","family":"Bouri","sequence":"additional","affiliation":[{"name":"West Middlesex University Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-3983","authenticated-orcid":false,"given":"Thomas","family":"Hamborg","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-3554","authenticated-orcid":false,"given":"Laura","family":"Miller","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2259-0948","authenticated-orcid":false,"given":"Christine","family":"Norton","sequence":"additional","affiliation":[{"name":"Florence Nightingale Faculty of Nursing Midwifery & Palliative Care, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"2025073013240715000_11.1.e001585.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.004"},{"key":"2025073013240715000_11.1.e001585.2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/WON.0b013e3182a9a8b5","article-title":"Help-seeking for fecal incontinence in people with inflammatory bowel disease","volume":"40","author":"Norton","year":"2013","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"2025073013240715000_11.1.e001585.3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/2049463719844539","article-title":"\u2018It\u2019s about willpower in the end. You\u2019ve got to keep going\u2019: a qualitative study exploring the experience of pain in inflammatory bowel disease","volume":"13","author":"Sweeney","year":"2019","journal-title":"Br J Pain"},{"key":"2025073013240715000_11.1.e001585.4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ecco-jcc\/jjw144","article-title":"What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance","volume":"11","author":"Hart","year":"2017","journal-title":"ECCOJC"},{"key":"2025073013240715000_11.1.e001585.5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12968\/gasn.2014.12.8.13","article-title":"Assessing fatigue in patients with inflammatory bowel disease","volume":"12","author":"Czuber-Dochan","year":"2014","journal-title":"Gastrointest Nurs"},{"key":"2025073013240715000_11.1.e001585.6","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-021-05466-4","article-title":"Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency\/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial","volume":"22","author":"Norton","year":"2021","journal-title":"Trials"},{"key":"2025073013240715000_11.1.e001585.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305600"},{"key":"2025073013240715000_11.1.e001585.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.011"},{"key":"2025073013240715000_11.1.e001585.9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.237"},{"key":"2025073013240715000_11.1.e001585.10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"2025073013240715000_11.1.e001585.11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"2025073013240715000_11.1.e001585.12","doi-asserted-by":"crossref","first-page":"i130","DOI":"10.1093\/ecco-jcc\/jjac190.0099","article-title":"DOP59 What is the relationship between fatigue, pain and urgency in people with inflammatory bowel disease? Results of the IBD-BOOST survey in 8486 participants","volume":"17","author":"Hart","year":"2023","journal-title":"J Crohn's Colitis"},{"key":"2025073013240715000_11.1.e001585.13","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1093\/ecco-jcc\/jjad212.0012","article-title":"OP12 Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn\u2019s Disease: Results from a phase 3 clinical trial","volume":"18","author":"Travis","year":"2024","journal-title":"J Crohn's Colitis"},{"key":"2025073013240715000_11.1.e001585.14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/apt.17242","article-title":"Effect of risankizumab on health-related quality of life in patients with Crohn\u2019s disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials","volume":"57","author":"Peyrin-Biroulet","year":"2023","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2024-001585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:24:13Z","timestamp":1753907053000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2024-001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,20]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/bmjgast-2024-001585"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2024-001585","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}